These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 14028342)

  • 21. Molecular blood grouping.
    Daniels G
    Vox Sang; 2004 Jul; 87 Suppl1():63-6. PubMed ID: 15200607
    [No Abstract]   [Full Text] [Related]  

  • 22. Noninvasive approaches to the management of RhD hemolytic disease of the fetus and newborn.
    Urbaniak SJ
    Transfusion; 2008 Jan; 48(1):2-5. PubMed ID: 18184231
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenous immunoglobulin in neonatal rhesus hemolytic disease.
    Greenough A
    Indian Pediatr; 2008 Aug; 45(8):649-50. PubMed ID: 18723906
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of a full-term infant with hemolytic disease of the newborn due to an anti-Rh17 antibody in a mother with D-- phenotype.
    Shah SI; Caprio M; Strauss R; Moskowitz N
    Am J Hematol; 2005 Sep; 80(1):88-9. PubMed ID: 16138349
    [No Abstract]   [Full Text] [Related]  

  • 26. [Placentography in feto-maternal iso-immunization due to Rhesus factor. Physiopathological and promostic importance].
    VITSE M; MONNIER JC
    Gynecol Obstet (Paris); 1962; 61():532-42. PubMed ID: 13997524
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemolytic diseases of the newborn caused by ABO incompatibility].
    TIMMERMAN J
    Belg Tijdschr Geneesk; 1963 Mar; 19():257-61. PubMed ID: 13985079
    [No Abstract]   [Full Text] [Related]  

  • 28. Symposium on haemolytic disease of the newborn with special reference to ABO incompatibility. Some problems of organization and prediction.
    BOWLEY CC
    Proc R Soc Med; 1963 Mar; 56(3):151-3. PubMed ID: 14014637
    [No Abstract]   [Full Text] [Related]  

  • 29. Symposium on haemolytic disease of the newborn with special reference to ABO incompatibility. Indications for and technique of exchange transfusion.
    TIZARD JP
    Proc R Soc Med; 1963 Mar; 56(3):156-8. PubMed ID: 13985195
    [No Abstract]   [Full Text] [Related]  

  • 30. The protective action of ABO incompatibility on Rh isoimmunization and Rh hemolytic disease; theoretical and clinical implications.
    LEVINE P
    J Med Educ; 1959 Apr; 34(4):418. PubMed ID: 13641945
    [No Abstract]   [Full Text] [Related]  

  • 31. [Incompatibility of maternal and fetal blood in the genesis of hemolytic disease in the newborn].
    DOSSENA G
    Riv Ostet Ginecol Prat; 1956 Sep; 38(9):748-56. PubMed ID: 13390629
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neonatal hemolytic disease with anti-c (=Anti-hr'=Anti-I)].
    KUHL I; VOIGT GE
    Zentralbl Gynakol; 1954; 76(11):434-45. PubMed ID: 13188346
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pathogenesis & treatment of hemolytic disease of the newborn due to the Rh factor: 330 cases].
    JOUVENCEAUX A; BRIZARD CP; MICHAUD D; REVOL L
    Pediatrie; 1958; 13(5):583-603. PubMed ID: 13600947
    [No Abstract]   [Full Text] [Related]  

  • 34. [Occurrence of neonatal fetal hemolytic disease in relation to phenotypes ABO and Rh distribution among population of Messina].
    Marsico S; Granese D; Volpe A
    Arch Ostet Ginecol; 1970; 75(2):156-62. PubMed ID: 5500667
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of the ABO system on Rh hemolytic disease.
    LEVINE P
    Hum Biol; 1958 Feb; 30(1):14-28. PubMed ID: 13513112
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term outcome of neonatal hyperbilirubinemia caused by isoimmunization. II. In the ABO system].
    DI CAGNO L; CASTELLO D; LANGE M
    Minerva Pediatr; 1963 Feb; 15():233-9. PubMed ID: 14027507
    [No Abstract]   [Full Text] [Related]  

  • 37. Rh hemolytic disease and autohemolytic disease. The possible role of agents other than antibodies in their pathogenesis.
    WIENER AS; BRANCATO GJ
    Exp Med Surg; 1961; 19():344-53. PubMed ID: 14006806
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemolytic disease of the newborn due to the rare blood factor, rhw(Cw).
    SACKS MO; SCHLUTZ C; DAGOVITZ L; VANECKO M
    Pediatrics; 1958 Mar; 21(3):443-4. PubMed ID: 13542089
    [No Abstract]   [Full Text] [Related]  

  • 39. [Histologic findings in the placenta in hemolytic disease].
    Tagliani L; Nappi R
    Arch Ostet Ginecol; 1966; 71(3):342-52. PubMed ID: 5973701
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fluoroscopic study of the placenta in hemolytic disease].
    La Torretta G; Pellicano A; Di Martino D; Chiàntera A
    Arch Ostet Ginecol; 1967; 72(2):101-13. PubMed ID: 5614553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.